Corrigendum: The Protective Effects of Lipid-Lowering Agents on Cardiovascular Disease and Mortality in Maintenance Dialysis Patients: Propensity Score Analysis of a Population-Based Cohort Study

Front Pharmacol. 2022 Mar 31:13:894462. doi: 10.3389/fphar.2022.894462. eCollection 2022.

Ming-Hsien Tsai^{1

2}, Mingchih Chen^{3

4}, Yen-Chun Huang^{3

4}, Hung-Hsiang Liou⁵, Yu-Wei Fang^{1

2}

¹ Division of Nephrology, Department of Internal Medicine, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei City, Taiwan.
² Department of Medicine, School of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
³ Graduate Institute of Business Administration, College of Management, Fu Jen Catholic University, New Taipei City, Taiwan.
⁴ AI Development Center, Fu Jen Catholic University, New Taipei City, Taiwan.
⁵ Division of Nephrology, Department of Internal Medicine, Hsin-Jen Hospital, New Taipei City, Taiwan.

Abstract

[This corrects the article DOI: 10.3389/fphar.2019.00079.].

Keywords: National Health Insurance Research Database; dialysis; lipid-lowering agents; major adverse cardiovascular events; mortality.